Marfan syndrome can cause life-threatening aortic complications. We investigated the relationship between FBN1 genotype and severe aortopathy (aortic root replacement, type A dissections, and related death).
M
arfan syndrome (MFS) is an autosomal dominant heritable disorder of the connective tissue that affects the cardiovascular, skeletal, ocular, and pulmonary systems. Recent surgical treatments for patients with ascending aortic aneurysms have improved their average life expectancy from around 30 years to >70 years. Surgical replacement of the aorta is recommended when the aortic diameter is ≥45 to 50 mm [1] [2] [3] ; however, it remains difficult to precisely predict when and how fast their aneurysms grow to a size at which surgery is indicated or rupture occurs. Thus, patients spend their childhood and adolescence under tremendous amounts of anxiety, despite receiving regular outpatient treatment, which includes β-blockers and angiotensin II receptor blockers, such as losartan.
Up to 97% of patients with MFS who fulfil the Ghent criteria have pathogenic variants in the FBN1 gene, 2 which encodes a major component of the extracellular matrix microfibril, namely fibrillin-1. MFS has been traditionally considered to result from the structural weakness of connective tissue. On the other hand, recent investigations on molecular mechanisms indicate that increased TGF-β (transforming growth factor-β) activity also plays a crucial role in the pathogenesis of MFS; fibrillin-1 can regulate TGF-β bioavailability, and the dysregulation of TGF-β contributes to the major extraocular features of MFS. 4 However, details regarding how FBN1 variants and altered TGF-β signaling are genetically and functionally involved in pathogenesis remain to be fully elucidated.
More than 3000 pathogenic variants, which are mostly unique among families, have been identified in the FBN1 gene. The penetrance of FBN1 variants for MFS is generally high, but phenotype prediction from variant types of the FBN1 gene has been a challenging task. However, though strong correlations between ectopia lentis and variants affecting or creating cysteine residues have been repeatedly reported in many publications, 5 practical guidelines that consider the relationship between genotype and phenotype have yet to be established.
Some recent studies have shown that patients with haploinsufficient type (HI) FBN1 variants, such as nonsense and frameshift variants that presumably cause nonsense-mediated mRNA decay, have more severe aortic phenotypes than those with missense variants. [5] [6] [7] [8] [9] However, further studies are warranted to replicate and extend these findings before introduction into clinical practice. In this study, we examined the effects of the FBN1 genotype on severe aortic events (aortic root replacement, type A dissections, and related death) and the progression of aortic root dilatation in 248 patients with pathogenic FBN1 variants.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedures.
Study Population and DNA Sequence Analysis
We performed genetic analysis for FBN1 gene variants (NM_000138.4) using Sanger sequencing in those suspected to have MFS. 10 In the present study, we enrolled consecutive patients with pathogenic or likely pathogenic FBN1 variants detected on genetic analysis performed between September 2006 and May 2017. The variants were classified as pathogenic or likely pathogenic based on the American College of Medical Genetics and Genomics−Association for Molecular Pathology classification guideline. 11 After excluding 12 patients with insufficient clinical information on the aortic events from 260 patients with pathogenic or likely pathogenic FBN1 variants, 248 patients were studied. This study was approved by the institutional ethics committee (G-1538).
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CLINICAL PERSPECTIVE
In Marfan syndrome, type A aortic dissection remains the leading cause of death. Up to 97% of patients with Marfan syndrome who fulfill the revised Ghent criteria have pathogenic variants in the FBN1 gene; however, the impact of the pathogenic FBN1 variants on the progression of aortic disease is poorly understood. In particular, patients with haploinsufficient type variants (resulting in reduced fibrillin-1 protein) have been reported to be at increased risk for aortic complications compared with those with dominant-negative (DN) variants (resulting in abnormal fibrillin-1 protein), whereas variants in exons 24 to 32 (mostly DN variants) are also known to be associated with earlier dilation of ascending aorta. In this retrospective study involving 248 patients with pathogenic or likely pathogenic FBN1 variants, we confirmed that those with haploinsufficient type variants had higher risk of aortic events than those with DN variants. Moreover, we newly defined a genetic subgroup within the slow-onset DN group based on the types and locations of FBN1 variants (DN-CD) and found that those with DN-CD were as deleterious as those with haploinsufficient type variants and were at a 6.3-fold higher risk than those with other types of DN variants (DN-nonCD). Risk assessment based on the simple genetic classification (ie, haploinsufficient type, DN-CD, and DN-nonCD) would give valuable directives and perspectives to patients with Marfan syndrome and their family members, who experience high levels of anxiety during their long-term follow-up period from childhood to old age.
Pathogenic Variant Classification
The pathogenic variants were classified under 2 main categories, HI and dominant-negative type (DN), based on their location and predicted amino acid alterations. Variants creating a premature termination codon or presumably abolishing the transcription of the gene were classified under the HI group and included (1) nonsense variants, (2) out-of-frame insertion or deletion variants, (3) out-of-frame exon-skipping variants caused by the splice donor site (eg, intron +1G or +2T) or splice acceptor site (eg, intron −1G or −2A), and (4) initiation codon variants (c.2T>A). Although these pathogenic HI variants are expected to cause haploinsufficiency because of nonsensemediated mRNA decay in nonsense variants, out-of-frame insertion or deletion variants, and out-of-frame exon-skipping variants caused by the splice donor or splice acceptor site and failure of protein translation in initiation codon variants, these are not molecularly proven. Variants classified under the DN group included (5) missense variants, (6) in-frame insertion or deletion variants, and (7) in-frame exon skipping variants, which are expected to exert DN effects.
Clinical Data
Clinical data were retrospectively collected based on patients' medical records kept at the University of Tokyo Hospital. Major manifestations and positive pertinent findings at the start of their continued hospital follow-up were classified into 1 of the following 11 categories based on their medical reports: (a) family history of MFS, (b) ectopia lentis, (c) tall stature, long limbs, and arachnodactylia, (d) kyphoscoliosis, (e) pectus carinatum and pectus excavatum, (f) pneumothorax, (g) mitral valve prolapse, (h) aortic dissection (type B), (i) aortic dilatation and aortic regurgitation, (j) aortic dissection (type A), and (k) others or unknown.
Severe aortic events were defined as occurrence of aortic root replacement, type A dissections and related death, and the event-free survival was calculated by sex using the Kaplan-Meier method. The aortic root diameter was measured at the referring hospital or our institute using transthoracic echocardiography at the level of the sinuses of Valsalva. Comparable echocardiographic data were obtained from the intact aortic root, and the last data for patient with severe aortic events were obtained only when data within 1 year before dissection or immediately before prophylactic aortic root surgery were available. To normalize the aortic root diameter to the patients' age and body size, age-and body surface area-adjusted echocardiographic aortic Z score (<20, 20-40, and ≥40 years of age) was calculated as described previously. Comparisons between categorical variables were made using the Fisher exact test. The event-free curve of the first aortic complication (aortic dissection, aortic surgery, and related death) was constructed using the Kaplan-Meier method and compared using the log-rank test. Univariate and multivariate Cox proportional hazards regression analyses were used to assess the relation between the FBN1 genotype and aortic events. P values <0.05 were considered statistically significant. We applied the Benjamini and Hochberg false discovery rate method 13 to derive corrected P values to address the issue of multiple testing among 3 genetic groups. Statistical analyses were conducted with R, version 3.4.1 (R Foundation).
RESULTS
Baseline Characteristics
A total of 248 patients (128 men and 120 women; age range, 2-80 years; median age, 31.3 years [IQR, 19.1-42.9]) from 202 Japanese families who had pathogenic or likely pathogenic FBN1 variants were studied (Table I in the Data Supplement). Among 248 patients, 225 (90.7%) patients fulfilled the revised Ghent criteria, whereas the remaining 23 (9.3%) children were enrolled as potential MFS considering their clinical and genetic features. Among these patients, 209 (84.3%) patients fulfilled the revised Ghent criteria without including genetic variant information. To examine the effects of pathogenic FBN1 variant types on the progression of aortic aneurysms and dissections, patients were subcategorized into 2 groups according to the predicted effects on protein structure and function: those carrying HI FBN1 variants and those with loss-offunction variants through a DN mechanism. However, the distinction had not been validated by comparing genomic DNA with complementary DNA from the mRNA of patient tissues (eg, aortic tissues and cultured fibroblasts from skin biopsies).
Among the 248 participants, 139 (56.0%) had already been diagnosed with MFS or potential MFS by the referring hospital. Variant types, age at the start of follow-up, and major manifestations or positive pertinent findings for continued hospital follow-up of both groups (DN, n=155 from 122 families; HI, n=93 from 80 families) are summarized in Figure 1 . The HI group included slightly more men than women (male percentage, 60.2% versus 46.5% in the HI and DN groups, respectively; P=0.037). Although no significant difference in the median age range was found between the 2 groups ( Figure 1B) , major manifestations or positive pertinent findings for continued hospital follow-up differed among age groups in both genotype groups (DN, P<0.0001; HI, P<0.001; Figure 1C ). Younger patients were often followed up because of ectopia lentis, marfanoid stature, and skeletal disorders, whereas disorders related to aortic events gradually increased with age. The large number of DN patients aged 0 to 6 years were being followed up for MFS, which presumably reflects the high prevalence of ectopia lentis in DN infants ( Figure 1B and 1C) .
Clinical Characteristics During Follow-Up
Clinical features and the incidence rate of aortic events (cardiovascular death, aortic dissection, and aortic surgery) from birth to the last follow-up visit or date of death are summarized in the 
Identification of a Group at High Risk for Severe Aortic Events Among DN Patients
Certain premature termination codon-containing transcripts that escape nonsense-mediated mRNA decay might be relatively stable and affect clinical outcomes differently, 14 especially in HI patients with variants at the C-terminal side. However, the location of HI variants did not affect the probability of severe aortic events ( Figure  I in the Data Supplement).
Subsequently, to identify patients at high risk for aortic events, we examined the genotype of 12 patients who had developed type A aortic dissection (n=1) and had undergone aortic root replacement (n=11) before the age of 20 years. Among the 7 DN variants ( Figure 3A ), 6 affecting conserved cysteine residues (4 variants affecting cysteine residues and 2 deletion variants [in-frame exon skipping]) were localized within tandem arrays of cb-EGF (calcium-binding epidermal growth factor)-like domains (exons 25-36 and 43-49) in the middle of the FBN1 gene (abbreviated as DN-CD variants henceforth; Figure 3B ). Among 46 children (<20 years of age) with DN variants, severe aortic event-free probability was significantly lower in 17 with DN-CD variants compared with 29 with DN-nonCD variants (P=0.011), as expected. Thus, we subsequently tested whether DN-CD variants are deleterious even in the remaining109 DN patients aged ≥20 years. Consistent with the pediatric cohort, the cumulative event-free survival was significantly lower in DN-CD (n=11) than in DN-nonCD (n=98) patients (P<0.001; Figure II in the Data Supplement), suggesting that among DN patients, those with DN-CD variants might be at increased risk for severe aortic events. Figure 4 shows that the median event-free survival period from birth (freedom from severe aortic events) was 30.0 years (95% CI, 19.0-42.0) for the DN-CD (n=28), 33.0 years (95% CI, 30.0-37.2) for the HI (n=93), and 52.0 years (95% CI, 43.0-57.0) for the DN-nonCD groups (n=127). Both DN-CD (unadjusted HR, 5.5; 95% CI, 2.9-10.5; corrected P value, <0.0001) and HI patients (unadjusted HR, 2.7; 95% CI, 1.7-4.2; corrected P value, <0.0001) had significantly higher risks of severe aortic events compared with DN-nonCD patients, whereas the difference between HI and DN-CD was not statistically significant (corrected P value, 0.062). Moreover, as shown in Figure III in the Data Supplement, DN-CD variants seemed to be more deleterious than variants within the so-called neonatal (or severe form) region, exons 24-32 15, 16 (11 patients were included in both groups).
Risk Assessment for Severe Aortic Events Based on the Newly Identified Genetic Subgroups and Sex
On multivariate analysis, the newly identified genetic subgroups (adjusted HR, 6.3; 95% CI, 3.3-11.8; P<0.0001 for DN-CD versus DN-nonCD; adjusted HR, 2.8; 95% CI, 1.8-4.4; P<0.0001 for HI versus DNnonCD) and male sex (adjusted HR, 2.6; 95% CI, 1.7-4.0; P<0.0001) were independently associated with a risk of severe aortic events. Even when type B aortic dissection was included in the severe aortic events, similar results were obtained for the genetic subgroups (adjusted HR, 5.5; 95% CI, 2.9-10.3; P<0.0001 for DN-CD versus DN-nonCD; adjusted HR, 2.8; 95% CI, 1.8- 4.4; P<0.0001 for HI versus DN-nonCD) and for male sex (adjusted HR, 2.2; 95% CI, 1.4-3.3; P=0.0002).
Moreover, multivariate analysis for the risk of severe aortic events (not including type B dissection) for only 202 index cases provided similar results for the genetic subgroups (adjusted HR, 6.1; 95% CI, 3.2-11.7; P<0.0001 for DN-CD versus DN-nonCD; adjusted HR, 3.0; 95% CI, 1.9-4.9; P<0.0001 for HI versus DNnonCD) and for male sex (adjusted HR, 2.8; 95% CI, 1.8-4.4; P<0.0001).
Rapid Aortic Root Diameter Growth in DN-CD, HI, and Male Patients
To further validate the impact of deleterious DN-CD and HI variants, we analyzed aortic root diameters measured through echocardiography when the aortic root was intact (if available). Data immediately before severe aortic events were obtained from 58 patients in the prophylactic surgery group (n=69) and 8 patients in type A or related death group (n=28). All data for the 151 aortic event-free patients (n=151) were available at least once. Figure Subsequently, we analyzed the relation between the FBN1 genotype and aortic root Z scores stratified by age (<20 and 20-40 years of age). Because the available body size data (height and weight) from the referring hospital were limited, especially in pediatric patients, data from patients with deleterious variants (DN-CD and HI) were collectively analyzed. DN-CD+HI patients had higher Z scores than DN-nonCD patients in both age groups ( Figure 5) .
Finally, we evaluated the progression rate of aortic root dilatation by sex in patients who had >3 years of follow-up data until 20 years of age and whose initial aortic root diameter was <40 mm (Figure 6 ). The aortic growth rate (millimeter per year) was higher in men than in women (men, Figure 6A and 6B). A comparison of rate of changes in Z score showed that the Z score increased in men between the first and last echocardiography but remained unchanged in women (men, P<0.001; women, P=0.24; Figure 6C and 6D). These results suggested that male patients <20 years of age were more likely to develop aneurysms than women.
DISCUSSION
The objective of this study is to elucidate the impact of the FBN1 genotype in MFS on the incidence of severe aortic events (aortic root replacement, type A dissections, and related death). Our results confirmed the Z scores for those <20 (A) and 20 to 40 y (B) of age were used. The DN-CD+HI group had higher aortic root Z scores than the DN-nonCD group in both age groups. The number of patients available was indicated in the lower part. main conclusion of the previous studies that HI patients had a higher risk of aortic events compared with DN patients, and male patients had an increased risk. In addition, we newly identified deleterious variants among DN patients, showing that those with variants affecting or creating cysteine residues and in-frame deletion variants in the cb-EGF domains of exons 25 to 36 and 43 to 49 (DN-CD variants) had a 6.3-fold higher risk for aortic events than DN-nonCD patients, which is comparable with or more deleterious than HI variants. Furthermore, aortic root diameter grew larger in DN-CD+HI than in DN-nonCD patients, and aneurysms were more likely to progress in men than in women. These results provide practical information for prognostic stratification of patients with MFS with pathogenic FBN1 variants.
The previous studies have suggested that HI patients have an increased risk for aortic events, and certain serious types of pathogenic FBN1 variants may exist: exons 24 to 32 have been recognized a critical region for the neonatal form of MFS, 16 which is characterized by severe mitral or tricuspid valvular insufficiency and pulmonary emphysema. 15 This has encouraged us to analyze clinical outcomes in our patients with MFS after simple subclassification into the HI or DN group. Although we have not verified HI or DN effects by checking the stability and function of the protein product, we think that our simple classification method could increase reliability and accessibility for clinical practice because of the following points: (1) the location of HI variants did not affect the probability of severe aortic events ( Figure I in the Data Supplement), which meant that HI variants were at a uniformly high risk for aortic events; (2) we identified a subset of patients with a more deleterious outcome (DN-CD group) within the slow-onset DN group; and (3) aortic root size was larger in DN-CD+HI than in DN-nonCD patients, with similar trends in the incidence rate of aortic events, when the aortic root was intact.
The underlying mechanisms in the relationship between genotype and aortopathy may not be as straightforward as it seems to be by the simple definition of genotype. Variability in phenotypes has been reported not only across families with the same FBN1 genotype but also within families, indicating that the pathogenic variant per se may not be the only determinant of phenotype severity. However, previous studies have suggested mechanisms that implicate FBN1 variant types in pathogenesis. (1) Variants associated with neonatal or severe forms of MFS cluster in a center region of fibrillin-1 (exons 24 to 32). [15] [16] [17] (2) Exons 44 to 49 may contribute to pathogenesis by regulating the bioavailability of endogenous TGF-β. 18 (3) Cysteine substitutions in the cb-EGF domains disrupt 1 of the 3 disulfide bonds that play an important role in protein structure stabilization, 19 and (4) calcium binding to cb-EGF modules plays a crucial role in microfibril stability and assembly. 20 (5) The complete loss of 1 FBN1 allele can lead to aortic root dilatation with high penetrance. 21 In the present study, DN-CD variants, which possessed some of the aforementioned properties (1-3), were considered deleterious among DN variants, although the precise mechanism needs to be further investigated.
The association between sex and the risk for aortic events has been reported previously. 8, 22, 23 Studies have consistently demonstrated that aortic root dilatation is more common in men than in women, and men have prophylactic aortic root surgery at a younger age than women. In the present study, the same trend was observed for the age at which prophylactic aortic root surgery had been done (men, 44; 26.1 years of age [IQR, .0]; women, 25; 35.0 years of age [IQR, 29.9-47.0]; P<0.01). The increased risk for aortic surgery has been speculated to be because of the absolute threshold for aortic surgery (45 to 50 mm) independent of body size and the larger overall body surface area of men. 8, 23 However, our results indicate that the rapid growth in men also contributed to this effect, although the underlying mechanism is unknown.
The present study has several limitations. First, this study is retrospective in design, and more than half of patients (56.0%) had already been diagnosed with MFS or potential MFS and followed up by the referring hospital with no uniform treatment policy. Only a few patients died during the follow-up at our hospital, and thus the mortality may have been underestimated. Most patients with type A aortic dissection (18 [64.3%] of 28 patients) had not been followed up at any hospital, and echocardiographic data of severe cases were not reflected in the analysis. Second, because of the limited sample size, the present study may have been underpowered to detect some differences between HI versus DN-CD in the risks of severe aortic events or in the aortic root diameters. These need to be evaluated in further investigations involving larger cohorts. Third, the effect of pathogenic variants on the stability and function of the protein product was not verified. Finally, given that our patients were all Japanese and the prophylactic surgical replacement of the aorta has been generally recommended at smaller sizes (45 mm), 1 application to other races may require some attention.
In conclusion, our study reflects the current status of the management and aortic outcomes of Japanese patients with MFS. Although the efficacy of continuous follow-up for preventing aortic dissection is doubtless, establishing disease guidelines reflecting the relationship between the FBN1 genotype and aortopathy would give valuable directives and perspectives to patients with MFS.
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